HHS sponsors development of drug for hospitalized influenza patients

HHS sponsors development of drug for hospitalized influenza patients

Development of an experimental influenza antiviral drug that may be more potent and could have a longer treatment window than existing drugs will receive support from the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR). The drug is being developed for use in treating patients hospitalized with influenza.

Read more about today's announcement.